Latest & greatest articles for adverse events

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adverse events or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adverse events and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for adverse events

81. Observational study: Emergency department visits and hospitalisations for adverse events related to dietary supplements are common

Observational study: Emergency department visits and hospitalisations for adverse events related to dietary supplements are common Emergency department visits and hospitalisations for adverse events related to dietary supplements are common | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user (...) name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Emergency department visits and hospitalisations for adverse events related to dietary supplements are common Article Text Aetiology/Harm Observational study Emergency department visits and hospitalisations for adverse events related to dietary supplements

Evidence-Based Medicine (Requires free registration)2016

82. Disclosure and Discussion of Adverse Events

Disclosure and Discussion of Adverse Events Disclosure and Discussion of Adverse Events - ACOG Menu ▼ Disclosure and Discussion of Adverse Events Page Navigation ▼ Number 681, December 2016 (Replaces Committee Opinion No. 520, March 2012) Committee on Patient Safety and Quality Improvement This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Patient Safety and Quality Improvement in collaboration with committee member Edward P. Denious (...) , MD. This document reflects emerging concepts on patient safety and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Disclosure and Discussion of Adverse Events ABSTRACT: Adverse outcomes, preventable or otherwise, are a reality of medical care. Most importantly, adverse events affect patients, but they also affect health care practitioners. Disclosing information about adverse events has benefits

American College of Obstetricians and Gynecologists2016

83. Adverse events in oncology patients with reduced platelet counts and oncurrent anemia

Adverse events in oncology patients with reduced platelet counts and oncurrent anemia Adverse events in oncology patients with reduced platelet counts and oncurrent anemia Adverse events in oncology patients with reduced platelet counts and oncurrent anemia Mitchell MD, Wagner J, Wong,TC, Mull N Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database (...) . Citation Mitchell MD, Wagner J, Wong,TC, Mull N. Adverse events in oncology patients with reduced platelet counts and oncurrent anemia. Philadelphia: Center for Evidence-based Practice (CEP). 2016 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Anemia; Humans; Leukopenia; Medical Oncology; Platelet Count; Thrombocytopenia Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence

Health Technology Assessment (HTA) Database.2016

84. Prospective evaluation of sedation-related adverse events in pediatric patients ventilated for acute respiratory failure

Prospective evaluation of sedation-related adverse events in pediatric patients ventilated for acute respiratory failure PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

PedsCCM Evidence-Based Journal Club2015

85. Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations.

Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations. IMPORTANCE: The Advisory Committee on Immunization Practices (ACIP) recommends the tetanus, diphtheria, and acellular pertussis (Tdap) vaccine for pregnant women during each pregnancy, regardless of prior immunization status. However, safety data on repeated Tdap vaccination in pregnancy is lacking. OBJECTIVE: To determine whether receipt of Tdap vaccine (...) during pregnancy administered in close intervals from prior tetanus-containing vaccinations is associated with acute adverse events in mothers and adverse birth outcomes in neonates. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study in 29,155 pregnant women aged 14 through 49 years from January 1, 2007, through November 15, 2013, using data from 7 Vaccine Safety Datalink sites in California, Colorado, Minnesota, Oregon, Washington, and Wisconsin. EXPOSURES: Women who received Tdap

JAMA2015

86. Emergency Department Visits for Adverse Events Related to Dietary Supplements.

Emergency Department Visits for Adverse Events Related to Dietary Supplements. BACKGROUND: Dietary supplements, such as herbal or complementary nutritional products and micronutrients (vitamins and minerals), are commonly used in the United States, yet national data on adverse effects are limited. METHODS: We used nationally representative surveillance data from 63 emergency departments obtained from 2004 through 2013 to describe visits to U.S. emergency departments because of adverse events (...) related to dietary supplements. RESULTS: On the basis of 3667 cases, we estimated that 23,005 (95% confidence interval [CI], 18,611 to 27,398) emergency department visits per year were attributed to adverse events related to dietary supplements. These visits resulted in an estimated 2154 hospitalizations (95% CI, 1342 to 2967) annually. Such visits frequently involved young adults between the ages of 20 and 34 years (28.0% of visits; 95% CI, 25.1 to 30.8) and unsupervised children (21.2% of visits; 95

NEJM2015

87. Adverse events associated with single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews.

Adverse events associated with single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews. BACKGROUND: This is an update of a Cochrane overview published in Issue 9, 2011; that overview considered both efficacy and adverse events. This overview considers adverse events, with efficacy dealt with in a separate overview.Thirty-nine Cochrane reviews of randomised trials have examined the adverse events associated with individual drug interventions in acute (...) postoperative pain. This overview brings together the results of those individual reviews. OBJECTIVES: To provide an overview of adverse event rates associated with single-dose oral analgesics, compared with placebo, for acute postoperative pain in adults. METHODS: We identified systematic reviews in The Cochrane Database of Systematic Reviews on The Cochrane Library through a simple search strategy. All reviews were overseen by a single review group. We extracted information related to participants

Cochrane2015

88. The Incremental Risk of Coronary Stents on Postoperative Adverse Events: A Matched Cohort Study

The Incremental Risk of Coronary Stents on Postoperative Adverse Events: A Matched Cohort Study 25894416 2016 04 08 2016 08 18 2017 03 10 1528-1140 263 5 2016 May Annals of surgery Ann. Surg. The Incremental Risk of Coronary Stents on Postoperative Adverse Events: A Matched Cohort Study. 924-30 10.1097/SLA.0000000000001246 To determine the incremental risk of coronary stents on adverse events in surgical patients and whether it varies over time from stent placement. Postoperative adverse (...) on surgical characteristics and cardiac risk factors. Outcomes of myocardial infarction (MI), revascularization, and death within 30 days after surgery were modeled using logistic regression. Adjusted risk differences between stented and nonstented populations were compared across time after stent placement. Adverse cardiac events followed surgery in 531 (5.7%) of the 9391 patients with stent and 680 (3.6%) of the 18,782 patients without stent (P < 0.001). In adjusted models, 30-day postoperative MI (odds

EvidenceUpdates2015

89. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization

Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization 25400060 2015 01 06 2015 03 26 2016 11 25 1524-4539 131 1 2015 Jan 06 Circulation Circulation Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. 19-27 10.1161/CIRCULATIONAHA.114.011939 Coronary (...) and severity of angiographic disease were estimated with the use of the CAD prognostic index, and CFR was measured noninvasively by positron emission tomography. A modest inverse correlation was seen between CFR and CAD prognostic index (r=-0.26; P<0.0001). After adjustment for clinical risk score, ejection fraction, global ischemia, and early revascularization, CFR and CAD prognostic index were independently associated with events (hazard ratio for unit decrease in CFR, 2.02; 95% confidence interval, 1.20

EvidenceUpdates2015

90. The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting

The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting 25541124 2014 12 26 2015 03 04 2017 03 10 1558-3597 64 25 2014 Dec 30 Journal of the American College of Cardiology J. Am. Coll. Cardiol. The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting. 2730-9 10.1016/j.jacc.2014.09.072 S0735-1097(14)06751-5 Recent coronary stent placement and noncardiac surgery contribute to the risk of adverse cardiac events (...) -risk surgery (ΔRD: 3.7%; p = 0.01), and drug-eluting stent (DES) (ΔRD: 1.3%; p = 0.01). The incremental risk of noncardiac surgery on adverse cardiac events among post-stent patients is highest in the initial 6 months following stent implantation and stabilizes at 1.0% after 6 months. Elective, high-risk, inpatient surgery, and patients with DES may benefit most from delay from a 6-month delay after stent placement. Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier

EvidenceUpdates2015

91. Cohort study: For patients who underwent elective non-cardiac surgery, a history of stroke is associated with an increased risk of major adverse cardiovascular events and death, particularly if time elapsed between stroke and surgery is less than 9?months

Cohort study: For patients who underwent elective non-cardiac surgery, a history of stroke is associated with an increased risk of major adverse cardiovascular events and death, particularly if time elapsed between stroke and surgery is less than 9?months For patients who underwent elective non-cardiac surgery, a history of stroke is associated with an increased risk of major adverse cardiovascular events and death, particularly if time elapsed between stroke and surgery is less than 9 months (...) who underwent elective non-cardiac surgery, a history of stroke is associated with an increased risk of major adverse cardiovascular events and death, particularly if time elapsed between stroke and surgery is less than 9 months Article Text Prognosis Cohort study For patients who underwent elective non-cardiac surgery, a history of stroke is associated with an increased risk of major adverse cardiovascular events and death, particularly if time elapsed between stroke and surgery is less than 9

Evidence-Based Medicine (Requires free registration)2015

92. Validation of the Risk Estimator Decision Aid for Atrial Fibrillation (RED-AF) for Predicting 30-Day Adverse Events in Emergency Department Patients With Atrial Fibrillation

Validation of the Risk Estimator Decision Aid for Atrial Fibrillation (RED-AF) for Predicting 30-Day Adverse Events in Emergency Department Patients With Atrial Fibrillation 25245277 2014 12 22 2015 04 20 2017 02 20 1097-6760 65 1 2015 Jan Annals of emergency medicine Ann Emerg Med Validation of the Risk Estimator Decision Aid for Atrial Fibrillation (RED-AF) for predicting 30-day adverse events in emergency department patients with atrial fibrillation. 13-21.e3 10.1016/j.annemergmed (...) .2014.08.023 S0196-0644(14)01222-0 In the United States, nearly 70% of emergency department (ED) visits for atrial fibrillation result in hospitalization. The incidence of serious 30-day adverse events after an ED evaluation for atrial fibrillation remains low. This study's goal was to prospectively validate our previously reported Risk Estimator Decision Aid for Atrial Fibrillation (RED-AF) model for estimating a patient's risk of experiencing a 30-day adverse event. This was a prospective cohort study

EvidenceUpdates2014

93. Long-term clinical outcome of major adverse cardiac events in survivors of infective endocarditis: a nationwide population-based study

Long-term clinical outcome of major adverse cardiac events in survivors of infective endocarditis: a nationwide population-based study 25223982 2014 11 04 2015 03 02 2014 11 04 1524-4539 130 19 2014 Nov 04 Circulation Circulation Long-term clinical outcome of major adverse cardiac events in survivors of infective endocarditis: a nationwide population-based study. 1684-91 10.1161/CIRCULATIONAHA.114.012717 Substantial infective endocarditis (IE)-related morbidity and mortality may occur even (...) % confidence interval [CI], 1.40-1.80), hemorrhagic stroke (aHR, 2.37; 95% CI, 1.90-2.96), myocardial infarction (aHR, 1.44; 95% CI, 1.17-1.79), readmission for heart failure (aHR, 2.24; 95% CI, 2.05-2.43), sudden death or ventricular arrhythmia (aHR, 1.69; 95% CI, 1.44-1.98), and all-cause death (aHR, 2.27; 95% CI, 2.14-2.40). Risk factors for repeat IE were older age, male sex, drug abuse, and valvular replacement after an initial episode of IE. Despite treatment, the risk of long-term major adverse

EvidenceUpdates2014

94. Propensity-weighted Long-term Risk of Urinary Adverse Events After Prostate Cancer Surgery, Radiation, or Both

Propensity-weighted Long-term Risk of Urinary Adverse Events After Prostate Cancer Surgery, Radiation, or Both 25217421 2015 03 12 2015 12 17 2016 10 25 1873-7560 67 2 2015 Feb European urology Eur. Urol. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. 273-80 10.1016/j.eururo.2014.08.061 S0302-2838(14)00816-1 Prostate cancer is the second most common cancer in men and has high survivorship, yet little is known about the long-term (...) risk of urinary adverse events (UAEs) after treatment. To compare the long-term UAE incidence across treatment and control groups. Using a matched-cohort design, we identified elderly men treated with external-beam radiotherapy (EBRT; n=44 318), brachytherapy (BT; n=14 259), EBRT+BT (n=11 835), radical prostatectomy (RP; n=26 970), RP+EBRT (n=1557), or cryotherapy (n=2115) for non-metastatic prostate cancer and 144 816 non-cancer control individuals from the population-based Surveillance

EvidenceUpdates2014

95. An exploration of the implementation of open disclosure of adverse events in the UK: a scoping review and qualitative exploration

An exploration of the implementation of open disclosure of adverse events in the UK: a scoping review and qualitative exploration An exploration of the implementation of open disclosure of adverse events in the UK: a scoping review and qualitative exploration An exploration of the implementation of open disclosure of adverse events in the UK: a scoping review and qualitative exploration Birks Y, Harrison R, Bosanquet K, Hall J, Harden M, Entwistle V, Watt I, Walsh P, Ronaldson S, Roberts D (...) , Adamson J, Wright J, Iedema R Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Birks Y, Harrison R, Bosanquet K, Hall J, Harden M, Entwistle V, Watt I, Walsh P, Ronaldson S, Roberts D, Adamson J, Wright J, Iedema R. An exploration of the implementation of open disclosure of adverse events in the UK: a scoping review and qualitative exploration

Health Technology Assessment (HTA) Database.2014

96. Predicting major adverse cardiac events in spine fusion patients: is the revised cardiac risk index sufficient?

Predicting major adverse cardiac events in spine fusion patients: is the revised cardiac risk index sufficient? 24825150 2014 07 30 2015 05 29 2014 07 30 1528-1159 39 17 2014 Aug 01 Spine Spine Predicting major adverse cardiac events in spine fusion patients: is the revised cardiac risk index sufficient? 1441-8 10.1097/BRS.0000000000000405 Observational cohort study. To determine the accuracy of the Revised Cardiac Risk Index (RCRI) in predicting major adverse cardiac events in patients (...) Gould Robert W RW Hemmer Laura B LB Bebawy John F JF Koski Tyler R TR McClendon Jamal J Jr Koht Antoun A Gupta Dhanesh K DK eng Journal Article Research Support, Non-U.S. Gov't United States Spine (Phila Pa 1976) 7610646 0362-2436 IM Adult Aged Aged, 80 and over Cohort Studies Female Heart physiopathology Heart Diseases etiology Humans Male Middle Aged Myocardial Infarction etiology Predictive Value of Tests Risk Assessment methods Risk Factors Spinal Fusion adverse effects Vascular Surgical

EvidenceUpdates2014

97. Meningitis B vaccine: useful in the event of an epidemic but adverse effects need to be more clearly identified

Meningitis B vaccine: useful in the event of an epidemic but adverse effects need to be more clearly identified Prescrire IN ENGLISH - Spotlight ''Meningitis B vaccine: useful in the event of an epidemic but adverse effects need to be more clearly identified'', 1 September 2014 {1} {1} {1} | | > > > Meningitis B vaccine: useful in the event of an epidemic but adverse effects need to be more clearly identified Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :   (...) |   |   |   |   |   |   |   |   |  Spotlight Meningitis B vaccine: useful in the event of an epidemic but adverse effects need to be more clearly identified The first vaccine against meningitis B has been authorised within the EU. This vaccine may be useful in the event of a meningitis epidemic, but further evaluation is required. Meningitis and other meningococcal infections are rare but serious, sometimes fatal, and can cause

Prescrire2014

98. Time elapsed after ischemic stroke and risk of adverse cardiovascular events and mortality following elective noncardiac surgery.

Time elapsed after ischemic stroke and risk of adverse cardiovascular events and mortality following elective noncardiac surgery. IMPORTANCE: The timing of surgery in patients with recent ischemic stroke is an important and inadequately addressed issue. OBJECTIVE: To assess the safety and importance of time elapsed between stroke and surgery in the risk of perioperative cardiovascular events and mortality. DESIGN, SETTING, AND PARTICIPANTS: Danish nationwide cohort study (2005-2011) including (...) all patients aged 20 years or older undergoing elective noncardiac surgeries (n=481,183 surgeries). EXPOSURES: Time elapsed between stroke and surgery in categories and as a continuous measure. MAIN OUTCOMES AND MEASURES: Risk of major adverse cardiovascular events (MACE; including ischemic stroke, acute myocardial infarction, and cardiovascular mortality) and all-cause mortality up to 30 days after surgery. Odds ratios (ORs) were calculated by multivariable logistic regression models. RESULTS

JAMA2014

99. Adverse drug event-related emergency department visits associated with complex chronic conditions

Adverse drug event-related emergency department visits associated with complex chronic conditions 24843054 2014 06 11 2014 07 30 2014 06 11 1098-4275 133 6 2014 Jun Pediatrics Pediatrics Adverse drug event-related emergency department visits associated with complex chronic conditions. e1575-85 10.1542/peds.2013-3060 Outpatient adverse drug events (ADEs) can result in serious outcomes requiring emergency department (ED) visits and hospitalizations. The incidence and severity of ADEs in children (...) Female Humans Insurance Claim Reporting statistics & numerical data Male Patient Admission statistics & numerical data Prescription Drugs adverse effects Retrospective Studies Risk Factors Statistics as Topic United States Utilization Review statistics & numerical data Young Adult adverse drug events complex chronic conditions drug safety emergency department special needs 2014 5 21 6 0 2014 5 21 6 0 2014 7 31 6 0 ppublish 24843054 peds.2013-3060 10.1542/peds.2013-3060

EvidenceUpdates2014 Full Text: Link to full Text with Trip Pro

100. An exploration of the implementation of open disclosure of adverse events in the UK: a scoping review and qualitative exploration

An exploration of the implementation of open disclosure of adverse events in the UK: a scoping review and qualitative exploration Anexplorationoftheimplementation ofopendisclosureofadverseevents intheUK:ascopingreviewand qualitativeexploration Yvonne Birks, 1* Reema Harrison, 2 Kate Bosanquet, 2 Jill Hall, 2 Melissa Harden, 3 Vikki Entwistle, 4 Ian Watt, 2 Peter Walsh, 5 Sarah Ronaldson, 2 David Roberts, 6 Joy Adamson, 2 John Wright 7 and Rick Iedema 8 1 Social Policy Research Unit, University (...) of adverse events, in terms of health care, refers to the practice of telling people if they have been harmed by a mistake when receiving care. In 2009, the National Patient Safety Agency relaunched its Being Open framework to support open disclosure in the UK. We explored how this guidance has been received, combining the literature on open disclosure with findings from interviews. We reviewed the international literature on open disclosure since 1980, identifying over 600 papers, predominantly from

NIHR HTA programme2014